Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by losingmyshirton Mar 24, 2021 11:19am

182 Views

Post# 32866299

Patience is a virtue.

I get it now. No one is buying because the general sentiment is that they can buy in later at .025.
That tells me that we have savy investors on this board.

343,179 x .045 = not a enough money to pay for pad space for Bob's popup trailer.

Sheeple, please do your best to support Kaly in thier hour of need.

Andrew needs to pay for more sailing lessons and none of you are doing your best to make it happen.

What more do you need? Andrew and Bob both told you in their own words that Kaly is the best. Why don't you believe them? It must be true if they said it.

Just like FACEBOOK where all the news is true and honest.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?